92 related articles for article (PubMed ID: 4135460)
1. Treatment of non-Hodgkin's lymphoma. Standard treatment.
Bunting WL
Ariz Med; 1974 Jun; 31(6):429-31. PubMed ID: 4135460
[No Abstract] [Full Text] [Related]
2. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)].
Sakano T
Rinsho Ketsueki; 1981 Feb; 22(2):159-77. PubMed ID: 7031290
[No Abstract] [Full Text] [Related]
3. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
Sampi K; Honda T; Hattori M
Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
[No Abstract] [Full Text] [Related]
4. Advances in adult non-Hodgkin's lymphoma. Current concepts of classification, diagnosis, and management.
Rassiga AL
Arch Intern Med; 1980 Dec; 140(12):1647-51. PubMed ID: 6161589
[TBL] [Abstract][Full Text] [Related]
5. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Klastersky J
Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
[No Abstract] [Full Text] [Related]
6. [Adjuvant chemotherapy for localized non-Hodgkin's lymphoma with CVP therapy].
Horikoshi N; Inagaki J; Ogawa M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1878-84. PubMed ID: 6683953
[TBL] [Abstract][Full Text] [Related]
7. New agents and combination chemotherapy of non-Hodgkin's lymphoma.
Skarin AT; Frei E; Moloney WC; Gutterman JU
Br J Cancer Suppl; 1975 Mar; 2():497-504. PubMed ID: 52368
[No Abstract] [Full Text] [Related]
8. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
9. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
10. [Maintenance treatment in non-Hodgkin's malignant lymphoma].
Geib KR; Guran M; Sighetea E
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):397-402. PubMed ID: 6143357
[No Abstract] [Full Text] [Related]
11. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H
Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
[No Abstract] [Full Text] [Related]
12. Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas.
Kinsella TJ
Cancer Treat Rep; 1982 Mar; 66(3):421-5. PubMed ID: 7037179
[No Abstract] [Full Text] [Related]
13. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
14. Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas.
Leimert JT; Corder MP; Tewfik HH; Guthrie R; Maguire LC; Gingrich RD
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1479-83. PubMed ID: 583417
[No Abstract] [Full Text] [Related]
15. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
[TBL] [Abstract][Full Text] [Related]
16. [Non-Hodgkin's lymphoma and pregnancy treated with chemotherapy. Report of a case].
Amaro A; Beristain C; Cárdenas JL; Mancera VJ; Ramírez G
Ginecol Obstet Mex; 1981 Feb; 49(292):117-21. PubMed ID: 6895203
[No Abstract] [Full Text] [Related]
17. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
Hehn ST; Miller TP
Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy].
Horikoshi N; Inagaki J; Ogawa M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1885-91. PubMed ID: 6683954
[TBL] [Abstract][Full Text] [Related]
20. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
